[PS] Plenary Session

[PS-3] Gene Transduction with the Engineered AAV Vector AAV.GT5 for Hemophilia B Gene Therapy

^○Yuji Kashiwakura¹, Kazuhiro Endo^2,3, Atsushi Ugajin⁴, Tomohiro Kikuchi⁴, Shuji Hishikawa^2,3, Hitoyasu Nakamura⁴, Yuko Katakai⁵, Nemekhbayar Baatartsogt¹, Takafumi Hiramoto¹, Morisada Hayakawa^1,6, Nobuhiko Kamoshita^1,6, Shoji Yamazaki⁷, Akihiro Kume^6,7, Harushi Mori⁴, Naohiro Sata^2,3, Yoichi Sakata¹, Shin-ichi Muramatsu^6,8,9, Tsukasa Ohmori^1,6 (1.Department of Biochemistry, Jichi Medical University School of Medicine, 2.Department of Surgery, Jichi Medical University School of Medicine, 3.Center for Development of Advanced Medical Technology, Jichi Medical University, 4.Department of Radiology, Jichi Medical University School of Medicine, 5.The Corporation for Production and Research of Laboratory Primates, 6.Center for Gene Therapy Research, Jichi Medical University, 7.Clinical Research Center, Jichi Medical University Hospital, 8.Devision of Neurological Gene Therapy, Center for Open Innovation, Jichi Medical University, 9.Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo)